ANKRD29 and non-small cell lung carcinoma: Overexpression of ANKRD29 significantly inhibited NSCLC cells’ proliferation and migration, and promoted the cancerous cells’ sensitivity to carboplatin and enhanced the killing ability of T cells in NSCLC cells.